Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

esuberaprost sodium

The sodium salt form of esuberaprost, the 314-d isomer of beraprost, with potential anti-inflammatory activity. Upon administration, esuberaprost activates the prostaglandin E2 receptor EP4 subtype (PTGER4; EP4), and inhibits the nuclear factor-kappa B (NF-kB) pro-inflammatory pathway. This may attenuate cytokine production and decrease inflammation.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	beraprost-314d
Code name:	CTO 1681 CTO-1681 CTO1681 GP 1681 GP-1681 GP1681

esuberaprost sodium

Search NCI's Drug Dictionary